Here’s a list of key deals reported across sectors this week:
Merck (MRK) to acquire Cidara Therapeutics (CDTX) for $221.50 per share in cash, for a total transaction value of approximately $9.2 billion.
Day One Biopharmaceuticals (DAWN) has signed a definitive

